Skip to content

Labcorp Holdings LH Free cash flow

Free cash flow at other companies

Azenta logo
AzentaAZTA
$6.11M-12.7%
NeoGenomics logo
NeoGenomicsNEO
-$13.14M+56.0%
Exagen Inc. logo
Exagen Inc.XGN
-$10.65M+1.3%
Castle Biosciences logo
Castle BiosciencesCSTL
-$34.58M-221%
Quest Diagnostics logo
Quest DiagnosticsDGX
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$3.5B+5.8%
Gross profit$1.0B+6.9%
Operating income$380.8M+16.8%
Net income$277.8M+30.5%
EPS (diluted)$3.35+32.9%

Balance sheet

See full
Cash & equivalents$981.1M+166%
Total debt$7.2B+11.1%
Total equity$8.7B+5.1%
Total assets$19.1B+8.4%

Cash flow

See full
Operating cash flow$191.5M+935%
CapEx$121.0M-4.0%

Valuation

See full
Market cap$22.96B+9.4%
Enterprise value$29.22B+10.7%
P/E24.4×-3.1×
P/S1.6×+0.1×

Profitability

See full
Gross margin28.8%+0.9pp
Operating margin10.2%+1.9pp
Net margin6.7%+1.1pp
FCF margin9.8%+1.0pp

Returns & leverage

See full
Return on equity11.1%+2.1pp
Debt / equity0.8×0.0×
Current ratio1.7×-0.1×

Where this comes from

Calculated from Labcorp Holdings’s reported figures.

The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Labcorp Holdings's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Labcorp Holdings's free cash flow?
Labcorp Holdings (LH) reported free cash flow of $70.5M in Q1 2026.
How has Labcorp Holdings's free cash flow changed year-over-year?
Labcorp Holdings's free cash flow increased by 165.6% year-over-year, from -$107.5M to $70.5M.
What is the long-term trend for Labcorp Holdings's free cash flow?
Over 4 years (2021 to 2025), Labcorp Holdings's free cash flow has grown at a -18.2% compound annual growth rate (CAGR), from $2.69B to $1.21B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.